SalesForce.com Inc. (CRM-N)

We tend to be faily cautious of a company after an earnings guidance warnings and  a large stock decline. The market is quite efficient in marking down large-cap names with weaker growth prospects, but also the guidance can give holders a 'reason' to sell over the next few months, especially if we see any general market weakness.  This could result in a re-rate for the company as growth slows down. That being said, CRM is a well-established company with a diversified portfolio of products, and the company has been and will still be around for quite some time. CRM also just transitioned into a more shareholder-friendly company by announcing dividends, and doing more buybacks. Overall, we would see it as a HOLD, with potentially a slow accumulate BUY into further weakness over the balance of 2024. Some patience is going to be required here but ultimately we think it recovers. 
Unlock Premium - Try 5i Free

After the close today, they reported a revenue miss and weaker guidance. Shares sank after hours. But they raised their full-year earnings forecast. The whole enterprise software space over-earned during Covid.

They report Wednesday. They do many things right, but don't get the credit for it. 

Excellent company, but investors used to good results. Would recommend for long term investors. 

Last quarter the stock fell 16%. Recent earnings better than expected. Would recommend buying.  

Core holding. 12-month price target of $330, good runway still. Still a buy at this level. Try for mid-$250s, and certainly in mid-$240s. 

In acquisition talks, so shares are down 5% today. It's testing its 100-day moving average, not since November. Was a serial buyer of businesses. He hopes AI is a way for them to grow. We'll see where the latest deal goes.

12-month price target of $318. Stick with it. Poster child of customer relationship management.

Is up 83% in the past year, thanks to new AI-related products. They reported after today's bell a modest top and bottom line beat and higher full-year sales forecast, but bears picked up on the light operating margin and revenue guidance a little weak. Shares are selling after hours, but shares also ran up before the report.

CRM saw three upgrades this week. A longtime favourite of his. It reports Wednesday. The stock may come in too hot before the report, which worries him, but if the quarter disappoints, buy it by Friday.

It is an obvious one for AI technology. In answer to the question don't trade it for NVDA. It's the same theme and they're both great.

You could take profits, but wait till they report. He'd sell calls around $285-290. There's going to be resistance around the high of October 2021. He'd add again around $260, and then $250.

Excellent company, and would recommend holding. Wait for share price weakness before buying given high valuation. 

An analyst upgrade noted a re-accelerating topline and a good EPS growth compounder.